Filter
1109
Filtered Results: 1109
Text search:
virus
emergentes
Featured
Recommendations
126
New Publications
280
Language
Document type
No document type
523
Studies & Reports
213
Guidelines
200
Strategic & Response Plan
71
Manuals
51
Fact sheets
20
Situation Updates
12
Online Courses
10
Training Material
7
Resource Platforms
1
Infographics
1
Countries / Regions
Global
47
India
41
Liberia
37
Sierra Leone
36
Latin America and the Carribbean
32
Africa
24
Nigeria
23
Brazil
23
Ethiopia
21
South Africa
19
Ghana
17
Venezuela
17
Guinea
16
Uganda
16
Tanzania
16
Colombia
14
Bangladesh
13
Senegal
12
Nepal
12
Zambia
11
Kenya
11
Namibia
11
Western and Central Europe
11
Paraguay
11
Mozambique
10
Argentina
10
Ecuador
10
West and Central Africa
10
Bolivia
9
Congo, Democratic Republic of
8
Malawi
8
Ukraine
8
East and Southern Africa
8
Zimbabwe
7
Niger
6
Pakistan
6
Afghanistan
6
Syria
6
Angola
6
Asia
6
Burkina Faso
5
Cameroon
5
Myanmar / Burma
5
Chile
5
Middle East and North Africa
5
Eastern Europe
5
Russia
5
Portugal
5
Mali
4
USA
4
Peru
4
Eswatini/ Swaziland
4
Honduras
4
Madagascar
4
South–East Asia Region
4
Spain
4
Côte d’Ivoire / Ivory Coast
3
Somalia
3
South Sudan
3
Sudan
3
Dominican Republic
3
El Salvador
3
Guatemala
3
Italy
3
Tunisia
3
Morocco
2
Philippines
2
Jordan
2
Germany
2
Turkey
2
Cambodia
2
Rwanda
2
Indonesia
2
Benin
2
North Macedonia
2
Serbia
2
Botswana
2
Libya
2
Mexico
2
Nicaragua
2
Yemen
2
Western Pacific Region
2
Armenia
2
Laos
2
Iran
2
Georgia
2
Gabon
2
Uruguay
2
Belarus
2
Guinea-Bissau
1
Saudi Arabia
1
Haiti
1
Iraq
1
Lebanon
1
Egypt
1
Chad
1
Thailand
1
China
1
Mauritania
1
Central African Republic
1
Cuba
1
Lesotho
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Kazakhstan
1
Vietnam
1
Belgium
1
France
1
Mauritius
1
United Kingdom
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
407
Clinical Guidelines
84
Public Health
56
Key Resources
36
Women & Child Health
18
Pharmacy & Technologies
16
Capacity Building
12
Annual Report MEDBOX
1
Toolboxes
COVID-19
229
Rapid Response
100
TB
84
HIV
82
AMR
67
Ebola
60
Planetary Health
56
Zika
31
NTDs
30
Polio
26
Mental Health
25
Global Health Education
20
Refugee
15
Pharmacy
12
Health Financing Toolbox
11
Conflict
10
Caregiver
8
NCDs
7
Natural Hazards
5
Specific Hazards
5
Cholera
4
Disability
2
Social Ethics
1
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected...
first issued 18 August 2022
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve hea...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Revised and expanded version of the Guidelines
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
Today, patient harm due to unsafe care is a large and growing global public health challenge and is one of the
leading causes of death and disability worldwide. Most of this patient harm is avoidable. As countries strive to
achieve universal health coverage and the Sustainable Development Goals, t...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
